Share

Sign up for the Faster Lane
email newsletter
August 30, 2012
Print Friendly

PremierTox to expand operations in Lexington, add 25 jobs

Drug screening firm to invest $250,000

FRANKFORT, Ky. (Aug. 30, 2012) — PremierTox 2.0 Inc. plans to expand operations by adding 25 jobs and investing $250,000 for equipment and improvements at its 10,000-square-foot facility in Lexington.

“The commonwealth is proud to work with company and community officials to make this project possible,” Gov. Steve Beshear said. “PremierTox is a tremendous asset for Lexington, with 25 new jobs on the way and an expanded resource for physicians, patients and businesses.”

PremierTox was established in 2010 in Russell Springs, Ky. to provide drug testing. The company has grown to serve customers in seven states, including Kentucky, and offers laboratory services; patient and physician services; toxicologist and medical review officer services; on-site specimen collections; in-office placement of complete testing centers; and billing services.

“PremierTox is dedicated to improving the lives of Kentucky citizens and communities,” said PremierTox CEO Eric Duncan. “Our goal is to provide the best laboratory services available and to partner with physicians and providers. As a Kentucky business hiring Kentucky residents, PremierTox helps the Commonwealth through job creation. PremierTox also is proud to be at the forefront of the war on drugs. A stronger, healthier and happier Kentucky is a goal we all share.”

The Kentucky Economic Development Finance Authority preliminarily approved the company for tax incentives up to $200,000 through the Kentucky Business Investment program. The performance-based incentive allows a company to keep a portion of its investment over the term of the agreement through corporate income tax credits and wage assessments by meeting job and investment targets.

For more information on PremierTox, visit www.premiertox.com. To apply for jobs, contact PremierTox at Human.Resources@PremierTox.com.

Print Friendly
Join The Discussion